Breakthrough NLC formulations enhance bioavailability of curcumin and EGCG, demonstrating 40% wrinkle reduction through dual collagen protection and SIRT1 activation, per 2024 clinical trials. Recent ...
Recent studies demonstrate herbal cubosomes enhance bioavailability of arthritis treatments by 40%, with clinical trials and industry partnerships paving the way for commercialization by 2026. Advance...
Breakthrough cubosome technology enhances bioavailability of curcumin and berberine, offering precise pancreatic beta-cell targeting and improved glycemic control in preclinical trials, challenging tr...
Breakthrough research reveals curcumin and EGCG in nanostructured lipid carriers enhance skin permeation by 35% and activate longevity pathways, though stability and scalability challenges persist. No...
Breakthrough nano-encapsulation technology enhances anti-inflammatory herbal compounds, with new FDA-fast-tracked therapy showing 79% pain reduction in trials. Experts analyze implications for arthrit...
Recent studies demonstrate Lawsonia inermis and Curcuma longa match synthetic dye performance while reducing toxicity, with 37% of EU labs now testing plant-based histopathology solutions. Emerging pl...
Breakthrough nanostructured lipid carriers enhance curcumin-EGCG delivery by 68%, combining SIRT1 activation with collagen protection, as major brands like L’Oréal rush to patent next-gen formu...
New chitosan-PVA-turmeric oil nanocomposite demonstrates potent antifungal activity against Pythium myriotylum, offering sustainable postharvest protection for ginger crops. Researchers develop pH-res...
Breakthrough nano-encapsulation technology boosts curcumin and EGCG bioavailability by 300%, with clinical trials showing 45% skin elasticity improvement, signaling a new era in evidence-based anti-ag...
Emerging research demonstrates herbal cubosomes’ superior anti-inflammatory drug delivery for arthritis, with recent trials showing 68% pain reduction and novel pH-responsive targeting developed...
